TOP TIERMARKET NEWSWIRE
SEC Form 4 history

LINEAGE CELL THERAPE (LCTX) insider trades

LINEAGE CELL THERAPE (LCTX) insider trading activity (SEC Form 4). Over the trailing 90 days, LCTX insiders filed 4 purchases totalling $854K and 0 sales totalling $0 — net BUYING of $854K. Most recent filing: Nov 19, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
4
$854K
Sells (90d)
0
$0
Net (90d)
+$854K
net buying
Most recent
Nov 19, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Nov 19, 2026Broadwood Partners, L.P.Dir, 10%P Purchase—$0.77$771Kfiling
Nov 19, 2026Mulroy Michael H.DirP Purchase—$0.87$26Kfiling
Nov 17, 2026Andrews Deborah JDirP Purchase—$0.80$20Kfiling
Nov 17, 2026Culley Brian MPres, CEOP Purchase—$0.92$37Kfiling